TrialNature medicine2021

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.

Ana C Medeiros-Ribeiro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.